Medication Utilization And Polypharmacy Among Geriatric Patients In Saudi Arabia: A Rapid Review

Abstract

This rapid review examines polypharmacy in geriatric patients (≥65 years) with multiple chronic conditions in Saudi Arabia, focusing on its prevalence and implications. Polypharmacy—concurrent use of five or more medications—poses significant risks, including adverse drug reactions, interactions, and financial burdens. Studies highlight challenges like reduced adherence, poorer quality of life, and increased healthcare complexity. Managing polypharmacy in older adults with comorbidities requires careful coordination among providers. Proposed interventions include regular medication reviews, standardized assessment tools, and collaborative care models involving pharmacists and physicians. Enhancing provider communication and awareness can optimize medication management. The review emphasizes the need for comprehensive strategies to mitigate polypharmacy risks, improve patient safety, and enhance health outcomes. Addressing this issue is critical as Saudi Arabia’s aging population grows. By implementing evidence-based approaches, healthcare systems can reduce polypharmacy-related harms and improve care quality for elderly patients with chronic diseases.